Medline Inc. <MDLN.O>: BMO cuts target price to $47 from $54
MDLN•Related News
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
LGND•
Brief-Suburban Propane Partners Q3 Net Income USD -17.527 Million
SPH•
Installed Building Products FY26 Q2 net income drops 5.94% to $64.9 million; revenue rises 2.3% to $777.8 million
IBP•
Exelixis Inc <EXEL.O>: Stifel Raises Target Price to $51 From $47
EXEL•
Immunovant Q1 net loss widens
IMVT•